treprostinil sodium

treprostinil sodium (TYVASO) is an FDA-listed pharmaceutical active ingredient. Associated with United Therapeutics Europe Ltd. Route of administration: inhalation. Current US regulatory status: approved.

TYVASO is a marketed brand name for treprostinil sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

treprostinil sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.